Clinical Trials

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT05812807 2026-03-04

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

1,295 enrolled

Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT05976763 2026-03-04

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Phase 4 Not yet recruiting

421 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

25 enrolled

Endometrial Neoplasms

NCT03516617 2026-02-09

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

LymphoidOther hematologic neoplasm

120 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Phase EARLY_PHASE1 Active not recruiting

34 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06733350 2026-02-09

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Suspended

600 enrolled

Prostatic Neoplasms

NCT07370675 2026-01-27

Active Surveillance for Bethesda IV Thyroid Nodules

165 enrolled

Phase 2/3 Active not recruiting

Thyroid Neoplasms, Thyroid Nodule

NCT05710406 2026-01-26

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

1 enrolled

Phase EARLY_PHASE1 Recruiting

Colonic Neoplasms

NCT07025226 2026-01-26

Senolytics

10 enrolled

CNS

Glioma

NCT02914873 2026-01-20

PCASTT

Phase NA Active not recruiting

2,008 enrolled

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07240220 2026-01-15

Merck-4

2,500 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

163 enrolled

CNS

Meningioma

NCT06378866 2025-12-26

DIVINE

532 enrolled

Prostatic Neoplasms

NCT03803553 2025-12-23

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

400 enrolled

Phase 2 Active not recruiting

Colonic Neoplasms

NCT04519879 2025-10-29

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

133 enrolled

Prostatic Neoplasms

NCT02882282 2025-10-23

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase 2 Completed

15 enrolled 8 charts

Mouth Neoplasms

NCT06200103 2025-09-11

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

236 enrolled

Prostatic Neoplasms

NCT02609685 2025-09-09

PMCAS

216 enrolled

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

688 enrolled

Urinary Bladder Neoplasms

NCT07023432 2025-06-17

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

78 enrolled

Carcinoma, Renal Cell

NCT06998342 2025-05-31

MOHSAHRTSS

24 enrolled

Head and Neck Neoplasms

NCT06861894 2025-05-15

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

164 enrolled

Esophageal Squamous Cell Carcinoma

NCT06974370 2025-05-15

ACTION-Brain

Phase 2/3 Active not recruiting

45 enrolled

CNS

Brain Neoplasms

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

635 enrolled 9 charts

Colonic Neoplasms

NCT06539468 2025-04-02

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

200 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT06686381 2025-02-05

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

80 enrolled

Muscle-invasive Bladder Cancer

NCT01725165 2024-10-24

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Phase 2 Completed

85 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT06238648 2024-09-26

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Phase 2 Active not recruiting

120 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00080756 2024-08-28

Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease

11 enrolled

Breast

Breast Neoplasms

NCT06089369 2024-04-30

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion

Phase 3 Not yet recruiting

360 enrolled

Phase NA Active not recruiting

Carcinoma, Hepatocellular

NCT04029714 2024-02-23

Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment

195 enrolled

Prostatic Neoplasms

NCT04489212 2024-02-08

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

2 enrolled

Phase EARLY_PHASE1 Terminated

Oropharyngeal Neoplasms

NCT03972943 2024-01-08

CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia

8 enrolled

Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Sleep Apnea, Obstructive

NCT01088750 2023-12-13

EuroNetLP1

Phase 4 Completed

225 enrolled

Lymphoid

Hodgkin Disease, Lymphoma

NCT01085630 2021-08-18

Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy

Phase 2 Completed

72 enrolled 12 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT04919460 2021-06-09

Research on Optimization and Evaluation of Oral Cancer Screening Methods

Phase EARLY_PHASE1 Unknown

10,000 enrolled

Mouth Neoplasms

NCT01717677 2021-02-10

PREFERE

Phase NA Terminated

457 enrolled

Prostatic Neoplasms

NCT00410683 2020-11-20

LUNG ART

Phase 3 Unknown

500 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01928485 2020-10-22

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Phase 2 Terminated

6 enrolled 23 charts

Prostatic Neoplasms

NCT03923777 2020-07-16

ACTION-Lung

Phase NA Unknown

26 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03804320 2020-02-11

Protocol Active Surveillance Small Renal Masses (SRMs)

180 enrolled

Kidney Neoplasms

NCT04135664 2019-10-22

Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma

176 enrolled

Esophageal Neoplasms

NCT01572428 2019-08-08

Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon

898 enrolled 15 charts

Colonic Neoplasms

NCT01795365 2018-09-28

Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer

Phase NA Terminated

60 enrolled

Adenocarcinoma of the Prostate

NCT02700724 2018-08-13

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

Phase NA Terminated

8 enrolled

Urinary Bladder Neoplasms

NCT02082470 2017-09-28

Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer

14 enrolled

Carcinoma, Ovarian Epithelial

NCT02029794 2017-05-03

ASPIRE

500 enrolled

Uterine Cervical Neoplasms

NCT00776100 2017-03-06

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Phase 2 Terminated

3 enrolled 4 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01313377 2017-01-25

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Phase 3 Completed

190 enrolled